Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples